Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of Asia Pacific Market by Virus Type	40
3.1 Market Overview by Virus Type	40
3.2 HSV-1	42
3.3 HSV-2	43
4 Segmentation of Asia Pacific Market by Drug Type	44
4.1 Market Overview by Drug Type	44
4.2 Acyclovir	46
4.3 Valacyclovir	47
4.4 Famciclovir	48
4.5 Other Drugs	49
5 Segmentation of Asia Pacific Market by Route of Administration	51
5.1 Market Overview by Route of Administration	51
5.2 Oral	53
5.3 Topical	54
5.4 Injection	55
6 Segmentation of Asia Pacific Market by Patient Gender	56
6.1 Market Overview by Patient Gender	56
6.2 Female	58
6.3 Male	59
7 Segmentation of Asia Pacific Market by Distribution Channel	60
7.1 Market Overview by Distribution Channel	60
7.2 Retail Pharmacies	62
7.3 Hospital Pharmacies	63
7.4 Online Pharmacies	64
7.5 Drug Stores	65
8 Asia-Pacific Market 2022-2032 by Country	66
8.1 Overview of Asia-Pacific Market	66
8.2 Japan	69
8.3 China	72
8.4 Australia	74
8.5 India	76
8.6 South Korea	78
8.7 Rest of APAC Region	80
9 Competitive Landscape	82
9.1 Overview of Key Vendors	82
9.2 New Product Launch, Partnership, Investment, and M&A	85
9.3 Company Profiles	86
Abbott	86
ADLEY FORMULATIONS	88
Aurobindo Pharma Ltd.	89
Avet Pharmaceuticals Inc.	90
Bausch Health Companies	91
Centurion Remedies	92
Cipla Ltd.	93
Eli Lilly & Company	94
Finecure Pharmaceuticals	95
GlaxoSmithKline Plc	96
Glenmark Pharmaceuticals	97
Macleods Pharmaceuticals	98
Medico Remedies	99
Merck & Co., Inc.	100
Novartis AG	101
Pfizer	102
Reddy's Laboratories	103
Sanofi SA	104
Teva Pharmaceutical Industries Ltd.	105
Torrent Pharma	106
Viatris Inc.	107
Zeelab Pharmacy	108
Zydus Pharmaceuticals, Inc.	109
RELATED REPORTS	110
?

List of Tables:

Table 1.  Snapshot of Asia Pacific Genital Herpes Treatment Market in Balanced Perspective, 2022-2032	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	28
Table 5.  Main Product Trends and Market Opportunities in Asia Pacific Genital Herpes Treatment Market	32
Table 6. Asia Pacific Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	40
Table 7. Asia Pacific Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	44
Table 8. Side Effects of Genital Herpes Medications	44
Table 9. Vaccine Pipelines for Herpes	50
Table 10. Asia Pacific Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn	51
Table 11. Asia Pacific Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn	56
Table 12. Asia Pacific Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	60
Table 13. APAC Genital Herpes Treatment Market by Country, 2022-2032, $ mn	67
Table 14. Japan Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	71
Table 15. Japan Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	71
Table 16. Japan Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	71
Table 17. China Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	73
Table 18. China Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	73
Table 19. China Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	73
Table 20. Australia Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	75
Table 21. Australia Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	75
Table 22. Australia Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	75
Table 23. India Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	77
Table 24. India Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	77
Table 25. India Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	77
Table 26. South Korea Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	79
Table 27. South Korea Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	79
Table 28. South Korea Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	79
Table 29. Genital Herpes Treatment Market in Rest of APAC by Country/Region, 2022-2032, $ mn	81
Table 30. Abbott: Company Snapshot	86
Table 31. Abbott: Business Segmentation	87
Table 32. Abbott: Product Portfolio	87

List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032	16
Figure 4. Asia Pacific Genital Herpes Treatment Market, 2022-2032, $ mn	19
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Genital Herpes Treatment Market	25
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million	28
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Genital Herpes Treatment Market	29
Figure 9. Investment Opportunity Analysis	33
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Genital Herpes Treatment Market	36
Figure 11. Breakdown of Asia Pacific Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue	41
Figure 12. Asia Pacific Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)	41
Figure 13. Asia Pacific Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn	42
Figure 14. Asia Pacific Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn	43
Figure 15. Breakdown of Asia Pacific Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue	45
Figure 16. Asia Pacific Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)	45
Figure 17. Asia Pacific Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn	46
Figure 18. Asia Pacific Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn	47
Figure 19. Asia Pacific Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn	48
Figure 20. Asia Pacific Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn	49
Figure 21. Breakdown of Asia Pacific Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue	52
Figure 22. Asia Pacific Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)	52
Figure 23. Asia Pacific Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn	53
Figure 24. Asia Pacific Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn	54
Figure 25. Asia Pacific Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn	55
Figure 26. Breakdown of Asia Pacific Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue	57
Figure 27. Asia Pacific Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)	57
Figure 28. Asia Pacific Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn	58
Figure 29. Asia Pacific Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn	59
Figure 30. Breakdown of Asia Pacific Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue	61
Figure 31. Asia Pacific Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)	61
Figure 32. Asia Pacific Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn	62
Figure 33. Asia Pacific Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn	63
Figure 34. Asia Pacific Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn	64
Figure 35. Asia Pacific Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn	65
Figure 36. Breakdown of APAC Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	67
Figure 37. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	68
Figure 38.  Genital Herpes Treatment Market in Japan, 2022-2032, $ mn	70
Figure 39.  Genital Herpes Treatment Market in China, 2022-2032, $ mn	72
Figure 40.  Genital Herpes Treatment Market in Australia, 2022-2032, $ mn	74
Figure 41.  Genital Herpes Treatment Market in India, 2022-2032, $ mn	76
Figure 42.  Genital Herpes Treatment Market in South Korea, 2022-2032, $ mn	78
Figure 43.  Genital Herpes Treatment Market in Rest of APAC, 2022-2032, $ mn	80
Figure 44. Growth Stage of Asia Pacific Genital Herpes Treatment Industry over the Forecast Period	82

Selected Key Players: 
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)